22 First interim analysis of a randomized trial comparing capecitabine/epirubicin/cyclophosphamide (XEC) vs 5-FU/epirubicin/cyclophosphamide (FEC) as adjuvant therapy for medium- or high-risk early breast cancer (EBC)
Z. Shao, B. Huang, J. Zhang, S. Zhou, P. He, D. Chen, S. Cui, C. Ren, L. Cai, J. ShiVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70053-7
File:
PDF, 49 KB
english, 2010